Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus haloperidol versus propofol for postoperative sedation in abdominal sepsis
PACTR202305682901262Not yet recruiting
- Sponsor
- sherif kamal hafez arafa
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine, haloperidol and propofol in abdominal sepsis and bowel obstruction (3 arms), sponsored by sherif kamal hafez arafa. Primary endpoints: Inflammatory mediators and Serum lactate level. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
dexmedetomidinehaloperidolpropofol
03
Conditions
abdominal sepsisbowel obstruction
Beyond the preview
Go deeper on PACTR202305682901262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202305682901262.